The cervical cancer screening program in Mexico: problems with access and coverage

Cancer Causes and Control

Volumn 8, Issue 5, 1997, Pages 698-704

  Lazcano Ponce, Eduardo César ^a   Nájera Aguilar, Patricia ^a   Buiatti, Eva ^b   Alonso De Ruiz, Patricia ^c   Kuri, Pablo ^d   Cantoral, Leticia ^a   Hernández Avila, Mauricio ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d Ctro Invest en Salud Poblacional ^*

Author keywords

Cervical cancer; Mexico; Pap test; Screening; Women

Indexed keywords

ARTICLE; FEMALE; HEALTH PROGRAM; HUMAN; MEDICAL INFORMATION; MEXICO; NONHUMAN; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; RURAL AREA; SCREENING; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MASS SCREENING; MEXICO; MIDDLE AGED; PROGRAM EVALUATION; RURAL HEALTH; SOCIAL CLASS; URBAN HEALTH; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030827810     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018471102911     Document Type: Article

References (40)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. Lazcano-Ponce E, Rascon-Pacheco R, Lozano-Ascencio, Velasco E. Mortality from carcinoma of the uterine cervix in Mexico: Impact of screening 1980-1990. Acta Cytologica 1996; 40: 506-12.
3. Beral V, Hermon C, Muñoz N, Devesa S. Cervical cancer. Trends in cancer incidence and mortality. Cancer Surv 1994; 19/20: 265-85.
4. Boring C, Squires T, Tong T. Cancer statistics 1992. CA Cancer J Clin 1992; 42: 19-38.
5. Hernández-Avila M, López-Acuña P. Epidemiología del cancer en la Ciudad de México. Resultados del Registro Nacional de Cáncer en 1988. In: Kumate J, Sepúlveda J, Gutiérrez G, eds. Información en Salud: La Salud en Cifras. Mexico City, Mexico: Fondo de Cultura Económics: 185-220.
6. Alonso de Ruiz P, Lazcano-Ponce E. Quality control in cytopathology laboratories in six Latin American countries. In: Wied G, Keebler C, Rosenthal D, Schenck U, Somrak T, Vooijs P, eds. Compendium on Quality Assurance, Proficiency Testing and Workload Limitations in Clinical Cytology. Chicago, IL (USA): Tutorials of Cytology, 1995: 115-21.
7. Lazcano-Ponce E, Alonso de Ruiz P, López-Carrillo L, Hernández-Avila M. Quality control study on negative gynecological cytology in Mexico. Diag Cytopathol 1994; 10: 10-4.
8. Lazcano-Ponce E, Rojas R, Lopez AM, López-Carrillo L, Hernández-Avila M. Factores reproductivos y riesgo de cancer cervicouterino en mujeres de la Ciudad de Mexico. Salud Publ Mex 1993; 35: 65-73.
9. Lazcano-Ponce E, Hernández-Avila M, López-Carrillo L, et al. Factores de riesgo reproductivo e historia de vida sexual asociados a cáncer cervical en una muestra de mujeres de la Cd. de México. Rev Invest Clin (Mex) 1995; 47: 377-85.
10. Nájera P, Lazcano-Ponce E, Alonso de Ruiz P, Ramírez T, Cantoral L, Hernández-Avila M. Factors associated with Mexican women's familiarity with the purpose of Pap test. Bulletin of PAHO 1996; 30: 348-53.
11. Bronfman M, Guiscafré H, Castro V, Castro R. La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med (Mex) 1988; 19: 351-60.
12. Hernández-Avila M, Lazcano-Ponce E, López L, Alonso de Ruiz P, Rojas R. Evaluación del programa de detección oportuna de cáncer cervical en México. Un estudio de casos y controles con base poblacional. Gaceta Médica, de México 1994; 130: 201-9.
13. SPSS, Inc. Statistical Package for the Social Sciences (SPSS/PC) Version 4. Chicago, IL (USA): SPSS, Inc. 1990.
14. Miller AB. Cervical Cancer Screening Programmes: Managerial Guidelines. Geneva, Switzerland: World Health Organization, 1992: 15-9.
15. Williams MA, Kenya PR, Mati JK, Thomas DB. Risk factors for invasive cervical cancer in Kenyan women. Int J Epidemiol 1994; 23: 906-12.
16. Van Oortmarssen G, Habbema JD. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative Pap smears. Int J Epidemiol 1995; 24: 300-7.
17. Wilcox LS, Mosher WD. Factors associated with obtaining health screening among women of reproductive age. Public Health Rep 1993; 108: 76-86.
18. Samelson E, Speers M, Ferguson R, Bennett C. Racial differences in cervical cancer mortality in Chicago. Am J Public Health 1994; 84: 1007-9.
19. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 1994; 272: 530-4.
20. Dignan M, Sharp P, Blinson K, et al. Development of a cervical cancer education program for Native American women in North Carolina. J Cancer Educ 1994; 9: 235-42.
21. Kang SH, Bloom JR, Romano PS. Cancer screening among African-American women: Their use of tests and social support. Am J Public Health 1994; 84: 101-3.
22. Yi JK. Factors associated with cervical cancer screening behavior among Vietnamese women. J Community Health 1994; 19: 189-200.
23. Guerra LG, Meza AD, Ho H, Casner PR, Moldes O. Medicine residents' practices in cancer screening in a Hispanic population. South Med J 1994; 87: 631-3.
24. Villar H, Menck H. The National Cancer Data Base Report on Cancer in Hispanics. Cancer 1994; 74: 2386-95.
25. Hislop TG, Band PR, Deschamps M, Clarke HF, Smith JM, Ng VT. Cervical cancer screening in Canadian Native women. Adequacy of the Papamcolaou smear. Acta Cytol 1994; 38: 29-32.
26. Curry RH, Moen JB, Morris SJ, Scheivelhud L. Community directed cancer screening program. Cancer Pract 1994; 2: 256-63.
27. Luneja A, Murthy NS, Sharma S, Shukla DK, Roy M, Das DK. Selective cervical cytology screening: discriminant analysis approach. Neoplasma 1993; 40: 401-4.
28. Lamont DW, Symonds RP, Brodie MM, Nwabineli NJ, Gillis CR. Age, socio-economic status and survival from cancer of cervix in the West of Scotland 1980-87. Br J Cancer 1993; 67: 351-7.
29. Sansom CD, MacInerney J, Oliver V, Wakefield J. Differential response to recall in a cervical screening programme. Br J Prev Soc Med 1975; 29: 40-7.
30. Cullum DE, Savory JN. Patient preference for cervical cytology. Br Med J 1983; 287: 329-32.
31. Naish J, Brown J, Denton B. Intercultural consultations: investigation of factors that deter non-English speaking women from attending their general practitioners for cervical screening. Br Med J 1994; 309: 1126-8.
32. Deschamps M, Band P, Hislop T, et al. Barriers to cervical cytology screening in Native Women in British Columbia. Cancer Detect Prev 1992; 16: 337-9.
33. Lazcano-Ponce E, Najera P, Alonso P, Buiatti E, Hernández-Avila M. Programa de detección Oportuna de Cancer Cervical en México. I. Diagnóstico Situacional. Rev Inst Nac Cancerología (Mex) 1996; 3: 123-40.
34. Ponten J, Olov H, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995; 60: 1-26.
35. Naish J, Brown J, Denton B. Intercultural consultations: Investigation of factors that deter non-English speaking women from attending their general practitioners for cervical screening. Br Med J 1994; 309: 1126-8.
36. Oleszkowicz KL, Kresch GM, Painter JK. Pap smear screening in family physicians' offices in a rural area with a high cervical cancer rate. Fam Med 1994; 26: 648-50.
37. Suarez L, Lloyd L, Weiss N, Rainbolt T, Pulley L. Effect of social networks on cancer-screening behaviour of older Mexican-American women. JNCI 1994; 86: 775-9.
38. Swaddiwudhipong W, Chaovakiratipong C, Nguntra P, Mahasakpan P, Lerdlukanavonge P, Koonchote S. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women. Int J Epidemiol 1995; 24: 493-8.
39. Austoker J. Cancer prevention in primary care. Screening for cervical cancer. Br Med J 1994; 309: 241-8.
40. Cox B, Skegg DCG. Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening. J Epidemiol Community Health 1992; 46: 373-7.